Archangels

Archangels is a prominent business angel syndicate based in Edinburgh, Scotland, focused on early-stage investing for over a quarter of a century. They aim to deliver outstanding returns for their investors by leveraging their experience and network to support Scottish entrepreneurs and innovators. Their mission is to provide members with curated opportunities to invest in innovative companies and support their development to their fullest potential. They typically invest over £10 million per year in early-stage Scottish companies, focusing on disruptive technology with protectable IP that is difficult for competitors to replicate. They are committed to their long-term role in maximizing investor returns, building and nurturing successful businesses, and helping Scotland prosper. Archangels provides ongoing support from its members, offering significant levels of investment in time and money to grow businesses in Scotland. They bring together the skills and experience of their members and their extensive network, and their portfolio companies, to achieve the best outcome for the businesses they support. They have a transparent and consistent approach to the investment process, and they act with a high degree of professionalism. They also provide support through all phases to help their portfolio companies achieve their ambitions and maximize returns for their investors. Their investment process includes a systematic search for new opportunities, building on strong contacts with universities, incubators, accelerators, and intermediaries. They screen business plans and conduct thorough pre-investment due diligence, considering the relationship with management, the addressable market size, and the uniqueness and disruptiveness of the technology. They align themselves with the interests of their member investors and portfolio companies, ensuring a collaborative approach.

Technology, Life Sciences, Software development, photonics, medical devices, bionics, underwater wireless networks, magnetic sensing, paper inhaler platform

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.